1-1 of 1
Martijn Heymans
Close
Sort by
Journal Articles

Splicing factor gene mutations in acute myeloid leukemia offer additive value if incorporated in current risk classification

Clinical Trials & Observations
Inge van der Werf, Anna Wojtuszkiewicz, Manja Meggendorfer, Stephan Hutter, Constance Baer, Martijn Heymans, Peter J. M. Valk, Wolfgang Kern, Claudia Haferlach, Jeroen J. W. M. Janssen, Gert J. Ossenkoppele, Jacqueline Cloos, Torsten Haferlach
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3254–3265.
https://doi.org/10.1182/bloodadvances.2021004556
Published: 2021
Includes: Supplemental data